Close Menu

NEW YORK (GenomeWeb) – Mobidiag, a Finnish molecular diagnostics maker, has entered an agreement with Chinese clinical diagnostics firm Autobio Diagnostics to establish a joint venture in China. Separately, Autobio Diagnostics has made a €10 million ($11.3 million) equity investment in Mobidiag, the firms announced today.

Mobidiag and Autobio will invest a total of €12.3 million to establish the joint venture company, with Autobio investing €8 million in the JV for a 65 percent stake, and Mobidiag investing €4.3 million for a 35 percent stake. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Associated Press reports that a state board in Texas has asked ANDE, a maker of rapid DNA machines, to halt its work there.

James Wyngaarden, the former director of the US National Institutes of Health, has died at 94, according to Duke University School of Medicine.

Researchers find that a 30-year-old skull comes from a narwhal-beluga hybrid, according to Science News.

In Nature this week: study of value diversity in GWAS, Epstein-Barr virus subtypes linked to nasopharyngeal carcinoma risk, and more.

Jul
24
Sponsored by
Hologic

This webinar will share the results of comparisons of commercially available nucleic acid amplification tests for use in routine screening of pregnant women for Group B Streptococcus (GBS).

Jul
30
Sponsored by
Mission Bio

This webinar will outline a project that performs large-scale and integrative single-cell genome and transcriptome profiling of pediatric acute lymphoblastic leukemia (ALL) cases at diagnosis, during drug treatment, and in case of relapse.